✦ LIBER ✦

Risk-benefit assessment of angiotensin II receptor antagonists

✍ Scribed by Shusterman, Neil

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic Benefits of Treating High-Risk

✍ Dr Antonio Coca 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 114 KB

Angiotensin II Receptor Antagonists

✍ Messerli, F H 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 63 KB

Angiotensin II receptor antagonists

✍ M Burnier; HR Brunner 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 118 KB

Nonpeptide angiotensin II receptor antag

✍ Pieter B.M.W.M. Timmermans; Pancras C. Wong; Andrew T. Chiu; William F. Herblin 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 940 KB

Angiotensin II antagonists offer additio

✍ Robert Carlson 📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 725 KB

Overview of angiotensin II-receptor anta

✍ Bertram Pitt; Marvin A Konstam 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 71 KB